Maya AI Logo

How can AI revolutionize medical and regulatory affairs?



Meet Maya AI

With the introduction of healthcare AI trends, it has drawn popular interest due to its potential to increase productivity and efficiency. Still, worries remain about how it may affect jobs and the dissemination of false information. The healthcare industry is one important area where AI might significantly impact. AI is defined, its potential is examined, and its effects on medical affairs are highlighted in this synopsis. It recommends proactive measurements for medical and regulatory affairs teams that can take to leverage AI to improve stakeholder service.

Medical affairs teams increasingly use AI technologies to understand the evolving demands of medical professionals and patients and to better meet those needs. Teams can use these tools to find essential trends that apply to most patients, which could result in enhanced patient care or patient support programs. Finding patterns in unstructured data can also be accomplished by using social listening strategies, such as monitoring social media comments or participating in online forums. As more businesses looked for solutions to employ natural language processing (NLP), it was predicted that NLP would be one of the biggest trends in healthcare in 2023-2024.

Socioeconomic information can be successfully extracted from free text notes, zip codes, appointment records, and payment habits using natural language processing approaches. Using this data, medical affairs teams may create AI algorithms that can more accurately anticipate patient needs and suggest the best action to meet them. One important thing to remember while utilizing NLP in medical concerns is to “tune the technology.” Pre-built ontologies and term libraries regularly updated and refined for increased precision, are used by linguamatics to extract themes and data points from documents and text-rich sources. Teams gain more significant insights, and there is less noise as a result.

AI and Big Data Integration Is Slower Than Expected

Although AI and big data have the potential to change the medical affairs sector completely, their adoption could be more active. This is because pharmaceutical businesses have to modify contracts, systems, and processes. After all, these tools cannot be added to the current ones. In addition, people’s hours are consumed by new technology through onboarding and training sessions. The successful use of electronic medical records necessitated creative software system integration and innovative procedures for communication between physicians, pharmacists, and other healthcare providers.

Adoption is not just behind in the medical field. Despite the great potential for adoption, researchers in the healthcare industry have observed that technology advancements could be more active. The promise of digital health still needs to be fulfilled despite tremendous advances over the past 20 years since using interoperable digital technology to enhance the efficacy, efficiency, equity, and continuity of care is still mostly theoretical.

Integrating AI into the IT stack is challenging and can alter how departments function. Big businesses can invest in technology because they have the means to do so, but their scale prevents them from rapidly implementing new systems. Because of this, MA teams generally find technology exciting but perceive it as still out of reach.

Medical and Data Governance: Evolving Around Tech

Healthcare is a complicated and quickly changing industry regarding AI and significant data use, and regulators are constantly working to safeguard patient information. There is a general impatience for alternative forms of care because the COVID-19 epidemic hastened the development of vaccinations. Medical teams must adjust to medical governance, which is proactive and forward-thinking in contrast to compliance. Professionals in this role now need to know about patient assistance programs, remote monitoring technologies, and digital health. To handle vast volumes of data, medical and regulatory teams need to hone their skills, and their organizations need to support them by constructing the required infrastructure. In addition to guaranteeing patient safety and extensive testing of novel treatments and pharmaceuticals before their release onto the market, this change in healthcare goes beyond simple compliance.

Medical and regulatory affairs teams have made great strides in the field but need help implementing AI and big data. 61% of participants in a survey conducted during the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting said they believed their team had control over their asset strategy. Teams must continue to fight for a seat at the table and show how they contribute value to their businesses to influence leadership. Big data is not only changing the way MA teams operate, but it’s also giving them a rare chance to demonstrate their strategic worth. Medical affairs professionals can spearhead the digital health revolution and improve their standing as a function that upholds scientific integrity by advocating the adoption of these tools.

The Challenges of Data And Operational Authority

The old authority structures in medicine are changing due to the introduction of AI technologies. AI tools gather data and make decisions independently, assisting doctors in their decision-making. Utilizing databases of biomarkers, medical records, and consumer information, these instruments provide diagnoses and focus preventive care. Virtual health assistants are provided by digital apps that track biometric data over time and provide appropriate medical attention to individuals who are managing illnesses. AI is also extending the function of operational tools by looking through patient files’ notes and reports to assist in selecting individualized care.

AI-powered maintenance systems that use cloud-based data and machine learning are also rapidly expanding. The most annoying thing about these AI systems is that they operate inside a “black box,” making it impossible for doctors to examine the verdict itself. In addition to replacing a doctor’s judgment, this “black-box” algorithm keeps the doctor from seeing the verdict. The effects of these products on the health sector’s established hierarchies of power still need to be addressed appropriately. Although AI-powered medicine has advantages, its “black-box” aspect prevents human oversight of tasks that are customarily the sole purview of doctors.

How Will AI Affect Regulation and Organization?

Since textbooks, diagnostic tests, and health records are informational tools that help with assessment and give knowledge, doctors have always been experts with them. To give patients direct care, a doctor uses operational instruments like lasers, defibrillators, and scalpels in addition to their expertise. Alongside the development of medical technologies came the emergence and rapid growth of maintenance tools, which are frequently connected to medical devices and pharmaceuticals. Heart pacemakers, prosthetic hips, insulin pumps, medications, and smartphone apps are made to continue working long after a doctor’s direct involvement has ended. These tools are valuable because they support the doctor by enabling continued care without direct supervision while prescribing therapy and monitoring the patient’s progress.

Several instruments are used to organize and regulate medicine. Informational tools are controlled by physician self-regulation; only other physicians are qualified to evaluate how a colleague uses the information. Outside of a HCP direct control, maintenance tools are subject to product liability law or the Food and Drug Administration (FDA). The FDA wants to ensure that safe maintenance items are available for purchase, giving doctors the power to prescribe. If a doctor’s usage of an operational tool becomes troublesome, the remedy falls under the purview of physician self-supervision. Operational tool oversight offers a mix of informational and maintenance tools. If the tool performs poorly, approving agencies will review it or investigate it under product liability law.

AI has the potential to support efforts in each of those areas:

  • Insight Generation- To find insights that might be helpful to MA’s purpose, a wide range of data sources could be analyzed using AI methods.
  • Strategy Development- The MA team must decide what to do with the valuable insights once they have been obtained and how to use them to develop strategies. Here, AI could help MA teams with their strategic orientation by pointing out and recommending best practices and analogs.
  • Evidence Generation – Within biopharma businesses, Medical Affairs increasingly serves as a center for generating evidence. AI’s ability to generate hypotheses and study designs could aid in the innovation of evidence generation.
  • Stakeholder Engagement – AI solutions can potentially improve engagement planning—that is, deciding who to talk to and when—and recommend the optimal course of action for interacting with patients, patient advocacy organizations, doctors, and other stakeholders.
  • Communication -Additionally, MA teams may be able to use AI techniques to offer real-time communication customization to important stakeholders.

More To Explore

Meet Maya AI
Updates/ PR

The New Maya Experience & Redesign

Maya AI Launches New Product Lines and Corporate Rebranding Personalized AI solutions that enhance team performance and customer experience. Share 05/21/24, Tampa, Fl — Maya

Subscribe to our newsletter to get latest news on your inbox.

Maya AI Logo